公司简介

ABOUT US

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Our strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VC Institutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, we have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors.

 

EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion. We have taken many years in the business and raised the core concept of 'taking entrepreneurs as the center and value creators as the basis'. With this concept, we have built an experienced and featured professional investment team. EFUNG also persists in a systematic operation that integrates investment, financing, risk control, management, and service. We have the confidence to become a well-grounded, people-oriented and trustworthy investment institution.

Why choose us?

为什么选择我们

创业板首家生态环境建设上市公司
中国生态修复和环境建设领军企业
国家级高新技术企业
中国环保产业骨干企业

Our histoty

发展历史

< >
  • 公司简介
  • 企业文化
  • 资质荣誉
  • 发展历程
    • Aboutus
      Aboutus
      Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Our strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VC Institutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, we have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion. We have taken many years in the business and raised the core concept of 'taking entrepreneurs as the center and value creators as the basis'. With this concept, we have built an experienced and featured professional investment team. EFUNG also persists in a systematic operation that integrates investment, financing, risk control, management, and service. We have the confidence to become a well-grounded, people-oriented and trustworthy investment institution.
温庚金 总经理

高级景观设计师

城市立体绿化专家

在城市立体绿化领域深耕多年,曾获立体绿化发明专利1项,世界屋顶绿化协会颁发的立体绿化设计与施工资格证书和空中花园建造师专业委员会委员证书,中国风景园林学会科技进步二等奖以及深圳市科技创新委员会颁发的关于《墙面绿化集成新技术研究》成果奖。
Our honor
资质荣誉 +
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务